Atika Capital Management »

Terns Pharmaceuticals shares owned by Atika Capital Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 321k 40.40

More positions owned by Atika Capital Management

Robinhood Mkts Com Cl A Put Option (HOOD)
Spdr Series Trust State Street Spd Put Option (XBI)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Shopify Cl A Sub Vtg Shs (SHOP)
Madrigal Pharmaceuticals (MDGL)
Bwx Technologies (BWXT)
Amazon (AMZN)
Cogent Biosciences (COGT)
Netflix (NFLX)
Talen Energy Corp (TLN)
Seagate Technology Hldngs Ord Shs (STX)

View all positions for Atika Capital Management

Top funds holding Terns Pharmaceuticals

BlackRock
Vanguard Group
Vivo Capital
Vestal Point Capital
Adage Capital Partners GP
Holocene Advisors
Franklin Resources
Lord, Abbett & Co
OrbiMed Advisors
Geode Capital Management
Ameriprise Financial
State Street Corporation
Acorn Capital Advisors
Nearwater Capital Markets
Citadel Advisors

View all funds holding Terns Pharmaceuticals